{
  "catalogId": "dffafb73-70fd-4b12-be5c-da23a444a760",
  "name": "VYVGART S.C. 180 MG/ML",
  "status": "",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "177 82 38001 00",
  "treatmentDescriptions": "Vyvgart is indicated as an add-on to standard therapy for the treatment of adult patients with generalised Myasthenia Gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection",
  "route": "s.c",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "EFGARTIGIMOD ALFA/",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L04AA58",
      "name": "EFGARTIGIMOD"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "VYVGART S.C. 180 MG/ML 1 VIAL",
      "manufacturer": {
        "name": "מדיסון",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "18",
      "storageConditions": "",
      "codes": {
        "moh": "9575"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 61271.72143,
        "retailMargin": 10.0,
        "maxRetailPrice": 67398.89357,
        "maxPriceWithVAT": 79530.69088
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T10:24:52.047388"
  }
}